Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.870 USD | -0.84% |
|
+4.63% | -45.15% |
06-06 | Bolt Biotherapeutics Announces 120 Reverse Stock Split Effective June 6, 2025 | RE |
05-12 | Bolt Biotherapeutics, Inc. - Special Call |
Executive Committee: Bolt Biotherapeutics, Inc.
Manager | Positions heldSince | ||||||
---|---|---|---|---|---|---|---|
William Quinn 53 year |
| ||||||
Grant Yonehiro 60 year |
| ||||||
Wesley Burwell |
| ||||||
Sarah Nemec 49 year |
|
Composition of the Board of Directors: Bolt Biotherapeutics, Inc.
Director | CommitteesSince | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Brian O'Callaghan 54 year |
| ||||||||||||
Kathy LaPorte 63 year |
| ||||||||||||
Jakob Dupont 60 year |
| ||||||||||||
Laura Berner 49 year |
| ||||||||||||
Nicole Onetto 71 year |
| ||||||||||||
William Quinn 53 year |
|
Latest Appointments: Bolt Biotherapeutics, Inc.
Former Officers and Directors: Bolt Biotherapeutics, Inc.
Insider | Positions held SinceUntil | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
|
Age distribution of managers
Parity Men Women
Male | 6 |
---|---|
Female | 3 |
Of which Executive Committee
Male | 3 |
---|---|
Female | 1 |
Of which Directors
Male | 4 |
---|---|
Female | 2 |
Revisions
Departures of Key Persons
Chief Executive Officer
Chairman
31/08/2016 14/11/2021
Chief Executive Officer
30/06/2019 14/05/2024
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition